Order ID:89JHGSJE83839 | Style:APA/MLA/Harvard/Chicago | Pages:5-10 |
Instructions:
Federal Drug Administration Essay Paper
This is an example of an ethical dilemma. Under the Federal Drug Administration (FDA), manufacturers are not supposed to disclose the results of medical research to the public domain (Kesselheim& Mello, 2007). On the other hand, manufacturers have a moral obligation to disclose the research information to the public, especially since the drug is now linked to cancer.
As the manufacturer, I would voluntarily disclose the study information to the public but under conditions. The FDA requires the drug manufacturers to undergo a long, expensive, and a multistep process that takes many years and includes numerous clinical on human subjects (Unlu, 2009). The manufacturer then files for investigational new drug application with the FDA. After the approval, the manufacturer continues with the human trials before filing a New Drug application (Unlu, 2009). In summary, the process of manufacturing drugs is laborious and time-consuming. All along, manufacturers pay for their cost of research data generation (Kesselheim& Mello, 2007). For this reason, research data should be kept confidential.
I would, therefore, disclose information that will not put our organization at risk. I would contact the Federal Drug Administration and ask for guidance on the best way forward before disclosing the information. Disclosing the research data promote public interests by getting rid of costs that result from keeping research data out of reach of the public. Unlu (2009) found that Merck did not disclose research information about its Vioxx’s after reports indicated that the drug was posing cardiovascular risks to patients. Disclosing the research information would boost the customers’ trust, a move that would make the company earn more. Since it is only preliminary research, it will allow the customers to evaluate the effectiveness of the drug and make an informed decision on whether to continue using our products (Kesselheim& Mello, 2007).
In summary, I would be more than willing to disclose the research information concerning our product since it is only preliminary research. I would, however, ensure that I protect the confidential information that would put the company at risk of losing the trade secrets.
According to me I would volunteer from myself and will disclose the information. Based on two grounds I would do that and if the information is ethical then the information can be disclosed to the customers. Based on the research from the history the breast implants which are covered here in this text will not be difficult for spotting a similar pattern here. Based on the full disclosure only the choices would be made by the buyers and they will require whole market information.
About the drugs, there will be information in the firms, and this will not be available or the purchasers. The final disclosure needs to be made not only from the ethical perspective, but they should also take from the litigation perspective. Here are some of the allegations which are raised on the fertility drugs that result in ovarian cancer. Based on the research we can to know that these drugs are been used by most women where this results in cancer (Kravdal & et al, 2017).
Correlation between Ovarian Cancer and Fertility Drugs
In the united states, most of the women have been suffered due to this drug and it causes cancer. Based on the researchers by many people I came to know that due to infertility this drug leads to cancer and harms many women’s health and increases the risks. For this problem there should be a treatment and infertility increased the need of treatment where all other health care systems are trying to play with the people’s health using some fertility drugs.
This raised a lot of consequences. The factor per se of infertility has been leading this cancer issue because they are using this fertility drug as there medication and this has come to know on the study research. To Vitro fertilization, this cancer is mainly related to and the changes which are made in this increase the fertilization were in increases the risks (QingAn & et al, 2018).
Conclusion
Cancer will posses to everybody through the use of the fertility drugs unusually where this is one of the drugs which decreases the fatal of a person (Roti & et al, 2014).
RUBRIC |
||||||
Excellent Quality 95-100%
|
Introduction
45-41 points The background and significance of the problem and a clear statement of the research purpose is provided. The search history is mentioned. |
Literature Support 91-84 points The background and significance of the problem and a clear statement of the research purpose is provided. The search history is mentioned. |
Methodology 58-53 points Content is well-organized with headings for each slide and bulleted lists to group related material as needed. Use of font, color, graphics, effects, etc. to enhance readability and presentation content is excellent. Length requirements of 10 slides/pages or less is met. |
|||
Average Score 50-85% |
40-38 points More depth/detail for the background and significance is needed, or the research detail is not clear. No search history information is provided. |
83-76 points Review of relevant theoretical literature is evident, but there is little integration of studies into concepts related to problem. Review is partially focused and organized. Supporting and opposing research are included. Summary of information presented is included. Conclusion may not contain a biblical integration. |
52-49 points Content is somewhat organized, but no structure is apparent. The use of font, color, graphics, effects, etc. is occasionally detracting to the presentation content. Length requirements may not be met. |
|||
Poor Quality 0-45% |
37-1 points The background and/or significance are missing. No search history information is provided. |
75-1 points Review of relevant theoretical literature is evident, but there is no integration of studies into concepts related to problem. Review is partially focused and organized. Supporting and opposing research are not included in the summary of information presented. Conclusion does not contain a biblical integration. |
48-1 points There is no clear or logical organizational structure. No logical sequence is apparent. The use of font, color, graphics, effects etc. is often detracting to the presentation content. Length requirements may not be met |
|||
![]() |
![]() |
|||||
![]() |
![]() |
![]() |
||||
You Can Also Place the Order at www.collegepaper.us/orders/ordernow or www.crucialessay.com/orders/ordernow
Federal Drug Administration Essay Paper |
Federal Drug Administration Essay Paper